McMaster University

McMaster University

Faculty of
Health Sciences

Mark Levine to head new institute for clinical trials

Published: October 30, 1998

Dr. Mark Levine, who has served as CEO of the Hamilton Regional Cancer Centre since 1992, will leave that post to spearhead the initiative to create a new Hamilton Clinical Research Institute at the Faculty of Health Sciences, McMaster University.

The new Institute will be a partnership with the Faculty and St. Joseph's Hospital and the Hamilton Health Sciences Corporation. Its activities will link closely with the expertise in the Faculty's internationally-renowned department of clinical epidemiology and biostatistics.

The Hamilton Clinical Research Institute will conduct clinical trials across the entire spectrum of medicine. Among its goals is the creation of an environment attractive to new researchers and one conducive to maximizing potential economic benefits for the community.

"We are delighted that Mark will be heading the new Institute," says Dr. Russell Joffe, dean and vice-president, health sciences. "This is a tremendous opportunity for all of the partners to consolidate the clusters of strong clinical research activities all across the region and create a new strategy under his capable direction."

"Mark has provided valuable leadership to the Cancer Centre," said Dr. Charles Hollenberg, president of Cancer Care Ontario, in announcing the departure. "He ensured the successful opening of the Centre in 1992, implemented program management, and established alliances with partners in the region. His has been an instrumental role in the creation of an effective cancer care network serving Central West Ontario."

"This is an exciting new direction for me on many levels," Levine says. "The opportunity to build upon existing strengths, the creation and enhancement of partnerships and linkages throughout the city, and the ability to attract new young investigators to this Institute will enhance our track record of international leadership in this area."

"One of the most important aspects of this initiative for us is the tremendous potential to benefit patients throughout Central West Ontario through increased opportunities for participation in leading edge clinical trials.

"Levine's appointment is effective July 1, 1999. Currently a professor of medicine and clinical epidemiology and biostatistics, he will remain very active in his own research and clinical care activities.

Valid XHTML 1.0 Transitional Level Double-A conformance, W3C WAI Web Content Accessibility Guidelines 2.0